论文部分内容阅读
针对社会上“广东中山三院存在超范围、大剂量用药的问题”的“齐二药”假药事件新说法,在6月12日的卫生部新闻发布会上,新闻发言人毛群安认为目前还没有证据支持这一点。毛群安说,首先,中山三院的医务人员在临床实践中发现了假药导致病人发生严重的用药反应,这是值得肯定和提倡的。如果没有中山三院及时发现问题,可能会引起更严重的后果。这也是长期以来我们要求医务人员在医疗活动中注意监测药品不良反应的结果。第二,这个事件发生后,卫生部及时组织专家组进行会诊,对整个医疗过程进行调查,也协助当地的卫生行政部门和医院,对曾经用过这个药品的病人治疗过程进行梳理和调查核实。这个事件发生后,卫
In response to a new statement on the issue of “Qi Er Yao” and “Fake Drugs” in the society that “there is an out-of-range and high-dose drug problem in the Zhongshan Third Hospital of Guangdong Province”, at a press conference of the Ministry of Health on June 12, Mao Qunan think there is no evidence to support this. Mao Qun’an said: First of all, medical staff from Zhongshan Hospitals found that fake drugs cause serious drug reactions in clinical practice, which is worthy of recognition and promotion. Without the timely detection of problems by the Zhongshan Hospital, it could have even more serious consequences. It is also the result of a long history of requiring medical personnel to monitor the adverse effects of medicines during their medical activities. Second, after this incident, the Ministry of Health promptly organized a group of experts to conduct consultations and conduct an investigation of the entire medical process. It also assisted the local health administrative departments and hospitals in sorting out and investigating the treatment of patients who used the drug. After this incident, Wei